Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 30.38M P/E - EPS this Y 7.20% Ern Qtrly Grth -
Income -48.93M Forward P/E -0.84 EPS next Y - 50D Avg Chg -25.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg -31.00%
Dividend N/A Price/Book 0.86 EPS next 5Y - 52W High Chg -67.00%
Recommedations 2.00 Quick Ratio 2.80 Shares Outstanding 5.47M 52W Low Chg 53.00%
Insider Own 0.31% ROA -72.22% Shares Float 5.02M Beta 1.72
Inst Own 13.25% ROE -171.26% Shares Shorted/Prior 63.89K/62.84K Price 7.97
Gross Margin - Profit Margin - Avg. Volume 372,934 Target Price -
Oper. Margin - Earnings Date May 17 Volume 6,924 Change -1.60%
About Hepion Pharmaceuticals, Inc.

Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of drug therapy treatment for chronic liver diseases in the United States. It develops Rencofilstat, a cyclophilin inhibitor is in Phase 2b clinical trial to target multiple pathologic pathways involved in the progression of liver disease and treat non-alcoholic steatohepatitis (NASH), as well as preclinical studies of Rencofilstat shows reduction in liver fibrosis, liver inflammation, liver tumor burden, and titers of HBV, HCV, HDV, and HIV-1, and has demonstrated antiviral activities for hepatitis B, C, and D viruses through several mechanisms. The company was formerly known as ContraVir Pharmaceuticals, Inc. and changed its name to Hepion Pharmaceuticals, Inc. in July 2019. Hepion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Edison, New Jersey.

Hepion Pharmaceuticals, Inc. News
03:30 PM Hepion Pharmaceuticals Initiates Wind-Down Activities in Phase 2b ‘ASCEND-NASH’ Trial
03/06/24 Hepion Pharmaceuticals Strengthens Board of Directors with Appointment of Michael Purcell
02/16/24 Hepion Pharmaceuticals Announces Exercise of Warrants for Approximately $2.0 Million Aggregate Gross Proceeds
01/03/24 Hepion Pharmaceuticals to Present at NASH-TAG 2024
12/07/23 Hepion Pharmaceuticals Announces Restructuring Plan to Enhance Shareholder Value and Management Changes
11/28/23 Hepion Pharmaceuticals to Present at the 7th Obesity & NASH Drug Development Summit
11/13/23 Hepion Pharmaceuticals Announces Major Reductions in Liver Stiffness with Rencofilstat Treatment in 17-week Phase 2 Study of Advanced (F3) MASH Liver Disease
11/10/23 Hepion Pharmaceuticals Schedules Conference Call to Review Additional Efficacy Data from Phase 2 ‘ALTITUDE-NASH’ Liver Function Trial of Rencofilstat
10/25/23 Hepion Pharmaceuticals’ Rencofilstat Demonstrates Anti-Cancer Activity in Hepatitis C-Associated Cancer Model
09/29/23 Hepion Pharmaceuticals Announces $5.0 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market under Nasdaq Rules
09/21/23 Hepion Pharmaceuticals to Participate in 2023 Cantor Global Healthcare Conference
09/21/23 New Anti-Cancer Opportunities Revealed for Hepion Pharmaceuticals’ Rencofilstat in Cancer Screening Program
08:41 AM Here's Why Hepion Pharmaceuticals (NASDAQ:HEPA) Must Use Its Cash Wisely
08:00 AM Hepion Pharmaceuticals Discovers Novel Rencofilstat Action in Liver Cancer
09/18/23 Insider Buying: Robert Foster Acquires 1,600 Shares of Hepion Pharmaceuticals Inc
09/14/23 Rencofilstat Produces Positive Outcomes in Translational Study on Idiopathic Pulmonary Fibrosis
09/06/23 Hepion Pharmaceuticals Announces Management Changes
06/15/23 Hepion Pharmaceuticals to Present Two Posters at EASL International Liver Congress™ 2023
06/15/23 Hepion Pharmaceuticals Announces Passing of Key Safety Milestone in Phase 2b ‘ASCEND-NASH’ Trial of Rencofilstat
05/24/23 Hepion Pharmaceuticals to Highlight AI-POWR™ at the 2023 CSPS Annual Symposium: The Next Frontiers in Pharmaceutical Sciences
HEPA Chatroom

User Image Hint1010 Posted - 35 minutes ago

$HEPA our company is even worse than Elizabeth Holmes. She did increase the value of shareholders before get caught! https://www.youtube.com/results?search_query=Elizabeth+Holmes

User Image Tacto Posted - 4 hours ago

$HEPA ..

User Image LousiaG2021 Posted - 9 hours ago

$HEPA $AUPH the problem of StockTwits is, there are way too many scam accounts to pump a stock.

User Image lifescience_investor Posted - 14 hours ago

$HEPA @Tacto you too can tell us what you own anytime now...

User Image lifescience_investor Posted - 14 hours ago

$HEPA

User Image Tacto Posted - 16 hours ago

$HEPA .

User Image Bunster Posted - 21 hours ago

$HEPA what a great statement engineer. AND IT WAS FROM OPENING I THINK LIKE AT 30C PRE RS TO 3 WEEKS LATER SOARING TO A BUCK WHICH U MENTIONED TO A 1 FOR 20 RS, to falling back TO MAY DATA CC SOARING BACK TO 20 to hobbs gone, a big offer at 5 ,to foster gone

User Image Bunster Posted - 21 hours ago

$HEPA THE DISNEYS and taco bell hardly pump and post anymore, do u think its because 1. they have been wrong and wronger and are loosing a ton of money WHICH HELLO THEY AINT GETTING BACK 2. the pps is .06 pre rs 3.They never had any idea of what they were talking about 4.They thought they had an endless supply of koolaide 6. the company has kind of ceased operations in a sense. 7. they stopped enrolling our main trial and i think the pumpers were telling their sheep we would be bought out for like 5 billion dollars or something.Those days of a 28 like (from the sheep)pumping nonsense posts are long gone.

User Image baurzhan16 Posted - 22 hours ago

$HEPA Fly me to the moon And let me play among the stars Let me see what spring is like on Jupiter and Mars

User Image nu2thezu Posted - 1 day ago

$HEPA I was recently reminded of a long ago contribution to our glorious forum here...so, in the spirit @Woosiedog has endeared us with, I'll continue to share the humor I see in this journey as well. I guess we should all say "I do"! lol

User Image Woosiedog Posted - 1 day ago

$HEPA for those of you needing a light humored break ( made me laugh )

User Image RatPoison Posted - 2 days ago

$HEPA

User Image RatPoison Posted - 2 days ago

$HEPA

User Image RatPoison Posted - 2 days ago

$HEPA

User Image StupediaTrades Posted - 2 days ago

$HEPA

User Image 5xStarTrader Posted - 2 days ago

$HEPA I looked up Armistice Capital's (AC) current holdings from their last 13f report for the quarter ending 3/31/24 to check on the 28,000 share change reflected on the NASDAQ institutional holdings page showing 390k remaining shares held out of the original 418k, bc I seem to remember that AC had stated in their original filing that they reserved the right to transfer some shares to an Armistice holding company, or partnership. The current AC 13f report shows that their total holdings of HEPA remains unchanged at 418k shares. (it is immediately below the General Electric symbol & listing). https://www.marketbeat.com/13f-filings/armistice-capital-llc/?all=1

User Image mahaparinirvan Posted - 2 days ago

$HEPA Feels like they're preparing for the next bad news to drop to push this below 1$....

User Image 5xStarTrader Posted - 3 days ago

$HEPA If a suitor simply purchases Hepion's R&D on Rencofilstat for the accrued losses of $224,000,000, which would give them an acquisition cost of only $161,280,000 bc of the 28% tax deductions of loss carry forwards allowing them to save $62,720,000 in profits, then Hepion's buyout stock price, when calculated at the fully diluted basis of 10 million shares, would be at $22.40 pps. If there is any value attributed to Rencofilstat for use in the treatment of any diseases, like for instance the MIT & Harvard Medical Universities Medical Center's joint clinical study showing that Rencofilstat reduced tumor burden between 50% - 100% in 86% of the 280 commonly diagnosed annual cancer cases, then the buyout price would be higher.

User Image PharmHand Posted - 3 days ago

$HEPA Robert Foster is an utter failure of a businessman.

User Image Kaizer21 Posted - 3 days ago

$HEPA They will never stop exercising their rights until the last day of the legal deadline, never

User Image Kaizer21 Posted - 3 days ago

$HEPA Last "5 calendar days".

User Image BADBOYROY Posted - 3 days ago

$HEPA bought more yesterday and today.

User Image BADBOYROY Posted - 3 days ago

$HEPA https://s3.amazonaws.com/sec.irpass.cc/2652/0001493152-24-019950.htm

User Image BADBOYROY Posted - 3 days ago

$HEPA NT 10 Q

User Image xx007xx Posted - 3 days ago

$HEPA the only thing certain here is the corruption, theft and short sellers active on this board. Armistice isn’t betting on an investment. They’re helping kill the stock.

User Image onetimeengineer Posted - 3 days ago

$HEPA The bleeding is not done.

User Image YoungTJ Posted - 3 days ago

$HEPA $0 soon

User Image 5xStarTrader Posted - 3 days ago

$HEPA I don't think Armistice Capital sold their 3 million shares today. Kind of curious as to what they based their purchase decision on for a cost average of $4.00 pps. One things for certain, they folks at Armistice are expecting something significant to happen that changes the price per share in a Bigly way...at least it's a pretty good guess that they placed their bets only after they saw the cards they would be holding.

User Image StupediaTrades Posted - 3 days ago

$HEPA $CADL

User Image 5xStarTrader Posted - 3 days ago

$HEPA They did this to CRIS and drove it to $1.00 pps, then it took off and ran up to $15.00 pps. It's down hard today by $2.77 to $13.00 on no news though.

Analyst Ratings
Brookline Capital Hold Dec 7, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Wijngaard Peter Director Director Nov 24 Buy 3.07 5,000 15,350 9,501 11/28/23
Wijngaard Peter Director Director Sep 15 Buy 5.57 3,000 16,710 4,501 09/20/23
Foster Robert T CEO and Director CEO and Director Sep 18 Buy 5.60 1,600 8,960 50,470 09/19/23
Foster Robert T CEO,CSO and Director CEO,CSO and Director Sep 15 Buy 5.40 1,600 8,640 48,870 09/18/23